N-(3-Acetylphenyl)-2-(2,4-dichlorophenoxy)acetamide

Catalog No.: 
ACZTXT122
CAS No.: 
42865-74-7
Molecular Formula: 
C16H13Cl2NO3
Molecular Weight: 
338.19
N-(3-Acetylphenyl)-2-(2,4-dichlorophenoxy)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$175.00InquiryInquiry
1g95%$407.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-Acetylphenyl)-2-(2,4-dichlorophenoxy)acetamide
IUPAC NameN-(3-acetylphenyl)-2-(2,4-dichlorophenoxy)acetamide
MDL No.MFCD01184136
Molecular FormulaC16H13Cl2NO3
Molecular Weight338.19
SMILESO=C(NC1=CC=CC(C(C)=O)=C1)COC2=CC=C(Cl)C=C2Cl
InChI KeyZFTNMESEAIJABG-UHFFFAOYSA-N
SynonymN-(3-Acetylphenyl)-2-(2,4-dichlorophenoxy)-acetamide;2-(2,4-dichlorophenoxy)-N-(3-ethanoylphenyl)ethanamide;AK-968/11368496;BAS 00539974;IVK/6223596;ZINC00258953;Acetamide, N-(3-acetylphenyl)-2-(2,4-dichlorophenoxy)-
CAS No.42865-74-7

Synthetic Route by SureRoute

1. ACZTXT122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRNS458 route compound structure diagram
    ACLRNS45899-03-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZTXT122 route product structure diagram
    ACZTXT12242865-74-7
Inquiry

2. ACZTXT122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRNS458 route compound structure diagram
    ACLRNS45899-03-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZTXT122 route product structure diagram
    ACZTXT12242865-74-7
Inquiry

3. ACZTXT122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRNS458 route compound structure diagram
    ACLRNS45899-03-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZTXT122 route product structure diagram
    ACZTXT12242865-74-7
Inquiry

Comments (0)